Ovarian Cancer Targeted Medication: PARP Inhibitors, Anti-Angiogenic Drugs, Immunotherapy, and More Ovarian cancer is the malignancy with the highest rate of death from tumors of the female ...
President Sheinbaum shared a plan to strengthen Mexico's semiconductor industry and touched on GMO corn and the U.S. DEA on ...
Scientists have successfully developed a gastric cancer model using 3D bioprinting technology and patient-derived cancer tissue fragments. This innovative model preserves the characteristics of actual ...
In Minnesota, one man provides free mental health services to farmers in all corners of the state. But recent legislation will give him more support. It’s one of several new state laws that ...
New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...
In November, virologist Beata Halassy announced to the world that she had cured her own breast cancer using a treatment ...
18h
AZoRobotics on MSNNew AI Platform Revolutionizes TB Drug Discovery by Analyzing Cell ImagesA study reveals AI's role in identifying antimicrobial compounds for tuberculosis, enhancing drug development through ...
Bushra Sumra’s career highlights the profound impact that expertise in clinical research and regulatory compliance can have ...
On the 5th, LG AI Research signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu, ...
Giverny Capital Asset Management, LLC, an investment management company, recently published its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trialData of on-going Phase 1b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results